|
1
|
Falagas ME and Kasiakou SK: Toxicity of
polymyxins: a systematic review of the evidence from old and recent
studies. Crit Care. 10:R272006. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Michalopoulos A and Falagas ME: Colistin
and polymyxin B in critical care. Crit Care Clin. 24:377–391. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Michalopoulos A, Kasiakou SK, Mastora Z,
Rellos K, Kapaskelis AM and Falagas ME: Aerosolized colistin for
the treatment of nosocomial pneumonia due to multidrug-resistant
Gram-negative bacteria in patients without cystic fibrosis. Crit
Care. 9:R53–R59. 2005. View
Article : Google Scholar
|
|
4
|
Zavascki AP, Goldani LZ, Li J and Nation
RL: Polymyxin B for the treatment of multidrug-resistant pathogens:
a critical review. J Antimicrob Chemother. 60:1206–1215. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Conway SP, Brownlee KG, Denton M and
Peckham DG: Antibiotic treatment of multidrug-resistant organisms
in cystic fibrosis. Am J Respir Med. 2:321–332. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Littlewood JM, Koch C, Lambert PA, et al:
A ten year review of colomycin. Respir Med. 94:632–640.
2000.PubMed/NCBI
|
|
7
|
Betrosian AP, Frantzeskaki F, Xanthaki A
and Douzinas EE: Efficacy and safety of high-dose
ampicillin/sulbactam vs. colistin as monotherapy for the treatment
of multidrug resistant Acinetobacter baumannii
ventilator-associated pneumonia. J Infect. 56:432–436. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Furtado GH, d’Azevedo PA, Santos AF, Gales
AC, Pignatari AC and Medeiros EA: Intravenous polymyxin B for the
treatment of nosocomial pneumonia caused by multidrug-resistant
Pseudomonas aeruginosa. Int J Antimicrob Agents. 30:315–319.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holloway KP, Rouphael NG, Wells JB, King
MD and Blumberg HM: Polymyxin B and doxycycline use in patients
with multidrug-resistant Acinetobacter baumannii infections
in the intensive care unit. Ann Pharmacother. 40:1939–1945. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oliveira MS, Prado GV, Costa SF, Grinbaum
RS and Levin AS: Ampicillin/sulbactam compared with polymyxins for
the treatment of infections caused by carbapenem-resistant
Acinetobacter spp. J Antimicrob Chemother. 61:1369–1375.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cheng CY, Sheng WH, Wang JT, Chen YC and
Chang SC: Safety and efficacy of intravenous colistin (colistin
methanesulphonate) for severe multidrug-resistant Gram-negative
bacterial infections. Int J Antimicrob Agents. 35:297–300. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kerr JF, Wyllie AH and Currie AR:
Apoptosis: a basic biological phenomenon with wide-ranging
implications in tissue kinetics. Br J Cancer. 26:239–257. 1972.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maroto R and Perez-Polo JR: BCL-2-related
protein expression in apoptosis: oxidative stress versus serum
deprivation in PC12 cells. J Neurochem. 69:514–523. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aravind L, Dixit VM and Koonin EV: The
domains of death: evolution of the apoptosis machinery. Trends
Biochem Sci. 24:47–53. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Spanos S, Rice S, Karagiannis P, et al:
Caspase activity and expression of cell death genes during
development of human preimplantation embryos. Reproduction.
124:353–363. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meng H, Li C, Feng L, et al: Effects of
Ginkgolide B on 6-OHDA-induced apoptosis and calcium over load in
cultured PC12. Int J Dev Neurosci. 25:509–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sasaki N, Toda T, Kaneko T, Baba N and
Matsuo M: Flavonoids suppress the cytotoxicity of linoleic acid
hydroperoxide toward PC12 cells. Biol Pharm Bull. 25:1093–1096.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hirata Y: Manganese-induced apoptosis in
PC12 cells. Neurotoxicol Teratol. 24:639–653. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ravni A, Bourgault S, Lebon A, et al: The
neurotrophic effects of PACAP in PC12 cells: control by multiple
transduction pathways. J Neurochem. 98:321–329. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Vaudry D, Chen Y, Hsu CM and Eiden LE:
PC12 cells as a model to study the neurotrophic activities of
PACAP. Ann N Y Acad Sci. 971:491–496. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hou RR, Chen JZ, Chen H, Kang XG, Li MG
and Wang BR: Neuroprotective effects of
(−)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis
in PC12 cells. Cell Biol Int. 32:22–30. 2008.
|
|
22
|
Li Y, Shi W, Zhou Y, et al:
Neuroprotective effects of chlorogenic acid against apoptosis of
PC12 cells induced by methylmercury. Environ Toxicol Pharmacol.
26:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shibata S, Maeda M, Furuta K, et al:
Neuroprotective effects of (arylthio)cyclopentenone derivatives on
manganese-induced apoptosis in PC12 cells. Brain Res. 1294:218–225.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmadian S, Barar J, Saei AA, Fakhree MA
and Omidi Y: Cellular toxicity of nanogenomedicine in MCF-7 cell
line: MTT assay. J Vis Exp. 11912009.PubMed/NCBI
|
|
25
|
Peng Q, Wei Z and Lau BH: Fructus corni
attenuates oxidative stress in macrophages and endothelial cells.
Am J Chin Med. 26:291–300. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee YM, Park SH, Shin DI, et al: Oxidative
modification of peroxiredoxin is associated with drug-induced
apoptotic signaling in experimental models of Parkinson disease. J
Biol Chem. 283:9986–9998. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng AC, Lee MF, Tsai ML, et al: Rosmanol
potently induces apoptosis through both the mitochondrial apoptotic
pathway and death receptor pathway in human colon adenocarcinoma
COLO 205 cells. Food Chem Toxicol. 49:485–493. 2011. View Article : Google Scholar
|
|
28
|
Pan MH, Chang WL, Lin-Shiau SY, Ho CT and
Lin JK: Induction of apoptosis by garcinol and curcumin through
cytochrome c release and activation of caspases in human leukemia
HL-60 cells. J Agric Food Chem. 49:1464–1474. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kawakami M, Inagawa R, Hosokawa T, Saito T
and Kurasaki M: Mechanism of apoptosis induced by copper in PC12
cells. Food Chem Toxicol. 46:2157–2164. 2008. View Article : Google Scholar
|
|
30
|
Woodgate A, MacGibbon G, Walton M and
Dragunow M: The toxicity of 6-hydroxydopamine on PC12 and P19
cells. Brain Res Mol Brain Res. 69:84–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Martin SJ and Green DR: Protease
activation during apoptosis: death by a thousand cuts? Cell.
82:349–352. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Breckenridge DG and Xue D: Regulation of
mitochondrial membrane permeabilization by BCL-2 family proteins
and caspases. Curr Opin Cell Biol. 16:647–652. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kluck RM, Bossy-Wetzel E, Green DR and
Newmeyer DD: The release of cytochrome c from mitochondria: a
primary site for Bcl-2 regulation of apoptosis. Science.
275:1132–1136. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang X, Wang Y, Luo J, Liu S and Yang Z:
Protective effects of YC-1 against glutamate induced PC12 cell
apoptosis. Cell Mol Neurobiol. 31:303–311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Basanez G, Sharpe JC, Galanis J, Brandt
TB, Hardwick JM and Zimmerberg J: Bax-type apoptotic proteins
porate pure lipid bilayers through a mechanism sensitive to
intrinsic monolayer curvature. J Biol Chem. 277:49360–49365. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c
release from mitochondria in response to activation of cell surface
death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goping IS, Gross A, Lavoie JN, et al:
Regulated targeting of BAX to mitochondria. J Cell Biol.
143:207–215. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gross A, Jockel J, Wei MC and Korsmeyer
SJ: Enforced dimerization of BAX results in its translocation,
mitochondrial dysfunction and apoptosis. EMBO J. 17:3878–3885.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Eskes R, Desagher S, Antonsson B and
Martinou JC: Bid induces the oligomerization and insertion of Bax
into the outer mitochondrial membrane. Mol Cell Biol. 20:929–935.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Narita M, Shimizu S, Ito T, et al: Bax
interacts with the permeability transition pore to induce
permeability transition and cytochrome c release in isolated
mitochondria. Proc Natl Acad Sci USA. 95:14681–14686. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Candé C, Cecconi F, Dessen P and Kroemer
G: Apoptosis-inducing factor (AIF): key to the conserved
caspase-independent pathways of cell death? J Cell Sci.
115:4727–4734. 2002.PubMed/NCBI
|
|
42
|
Candé C, Cohen I, Daugas E, et al:
Apoptosis-inducing factor (AIF): a novel caspase-independent death
effector released from mitochondria. Biochimie. 84:215–222.
2002.PubMed/NCBI
|
|
43
|
Wei MC, Lindsten T, Mootha VK, et al:
tBID, a membrane-targeted death ligand, oligomerizes BAK to release
cytochrome c. Genes Dev. 14:2060–2071. 2000.PubMed/NCBI
|
|
44
|
Csokay B, Prajda N, Weber G and Olah E:
Molecular mechanisms in the antiproliferative action of quercetin.
Life Sci. 60:2157–2163. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zimmermann KC and Green DR: How cells die:
apoptosis pathways. J Allergy Clin Immunol. 108:S99–S103. 2001.
View Article : Google Scholar : PubMed/NCBI
|
